Accretive Health Provides Updated Timeline for Completion of Restatement
December 19 2014 - 7:35PM
Business Wire
Expects to File 2013 Form 10-K and Hold
Business Update Call on Dec. 30
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it
is in the final stages of completing its financial restatement. The
Company currently expects to file its Annual Report on Form 10-K
for the year ended December 31, 2013 with the Securities and
Exchange Commission (SEC) after the market closes on December 30,
2014. The 2013 Form 10-K will include results for the fiscal years
ended December 31, 2013 and December 31, 2012, and restated results
for the fiscal year ended December 31, 2011. The company previously
announced on November 12, 2014 that it expected to complete its
restatement and related audits, and to file the 2013 Form 10-K by
the middle of December.
Conference Call and Webcast Details
Accretive Health’s management team will host a conference call
on December 30, 2014 at 3:30 p.m. CT (4:30 p.m. ET) to discuss the
restatement and business outlook. To participate, please dial
877-280-4954 (857- 244-7311 from outside the U.S. and Canada) using
conference code number 32430071, or visit the Investor Relations
section of Accretive Health’s web site at www.accretivehealth.com
to access the live webcast. A replay will be available for one week
following the conference call at 888-286-8010 (617-801-6888 from
outside the U.S. and Canada) using conference code number 46013693.
A replay of the conference call will also be available online at
www.accretivehealth.com.
About Accretive Health
At Accretive Health, our mission is to partner with healthcare
communities to serve as a catalyst for a healthier future for all.
For more information, visit www.accretivehealth.com.
Safe Harbor
This press release contains forward-looking statements,
including the statements regarding the Company’s ability to file
its Annual Report on Form 10-K for the year ended December 31,
2013. All forward-looking statements contained in this press
release involve risks and uncertainties. Our actual results and
outcomes could differ materially from those anticipated in these
forward-looking statements as a result of various factors,
including the possibility that our ongoing restatement could have
unanticipated consequences and the factors set forth in the
Company’s quarterly report on Form 10-Q for the quarter ended
September 30, 2012, filed with the SEC on November 8, 2012, under
the heading “Risk Factors”. The words “strive,” “objective,”
“anticipates,” “believes,” “estimates,” “expects,” “intends,”
“may,” “plans,” “projects,” “vision,” “would,” and similar
expressions are intended to identify forward-looking statements,
although not all forward-looking statements contain these
identifying words. The Company has based these forward-looking
statements on its current expectations and projections about future
events. Although the Company believes that the expectations
underlying any of its forward-looking statements are reasonable,
these expectations may prove to be incorrect and all of these
statements are subject to risks and uncertainties. Should one or
more of these risks and uncertainties materialize, or should
underlying assumptions, projections, or expectations prove
incorrect, actual results, performance, financial condition, or
events may vary materially and adversely from those anticipated,
estimated, or expected.
All forward-looking statements included in this press release
are expressly qualified in their entirety by these cautionary
statements. The Company cautions readers not to place undue
reliance on any forward-looking statement that speaks only as of
the date made and to recognize that forward-looking statements are
predictions of future results, which may not occur as anticipated.
Actual results could differ materially from those anticipated in
the forward-looking statements and from historical results, due to
the uncertainties and factors described above, as well as others
that the Company may consider immaterial or does not anticipate at
this time. Although the Company believes that the expectations
reflected in its forward-looking statements are reasonable, the
Company does not know whether its expectations may prove correct.
The Company’s expectations reflected in its forward-looking
statements can be affected by inaccurate assumptions it might make
or by known or unknown uncertainties and factors, including those
described above. The risks and uncertainties described above are
not exclusive, and further information concerning the Company and
its business, including factors that potentially could materially
affect its financial results or condition or relationships with
customers and potential customers, may emerge from time to time.
The Company assumes no, and it specifically disclaims any,
obligation to update, amend, or clarify forward-looking statements
to reflect actual results or changes in factors or assumptions
affecting such forward-looking statements. The Company advises
investors, however, to consult any further disclosures it makes on
related subjects in our periodic reports that it files with or
furnishes to the SEC.
Accretive Health, Inc.Investor Relations:Atif
Rahim312.324.5476investorrelations@accretivehealth.comorMedia
Relations:Brian Pitts312.475.5921brian.pitts@hkstrategies.com
R1 RCM (NASDAQ:RCM)
Historical Stock Chart
From Mar 2024 to Apr 2024
R1 RCM (NASDAQ:RCM)
Historical Stock Chart
From Apr 2023 to Apr 2024